Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Defects, Congenital | 88 | 2024 | 4584 | 6.330 |
Why?
|
Cardiac Surgical Procedures | 43 | 2023 | 3537 | 2.930 |
Why?
|
Hospital Mortality | 22 | 2019 | 5317 | 1.450 |
Why?
|
Developing Countries | 11 | 2023 | 2815 | 1.420 |
Why?
|
Pulmonary Veins | 11 | 2021 | 761 | 1.330 |
Why?
|
Cardiology | 15 | 2023 | 1668 | 1.240 |
Why?
|
Risk Adjustment | 11 | 2012 | 594 | 1.140 |
Why?
|
Pulmonary Veno-Occlusive Disease | 7 | 2015 | 66 | 1.110 |
Why?
|
Quality Indicators, Health Care | 10 | 2017 | 1831 | 1.100 |
Why?
|
Quality Improvement | 18 | 2020 | 3749 | 1.050 |
Why?
|
Constriction, Pathologic | 9 | 2019 | 1107 | 1.010 |
Why?
|
Infant | 77 | 2021 | 35136 | 0.990 |
Why?
|
Infant, Newborn | 57 | 2020 | 25625 | 0.870 |
Why?
|
Child, Preschool | 63 | 2020 | 41006 | 0.840 |
Why?
|
Aortic Coarctation | 5 | 2018 | 281 | 0.830 |
Why?
|
Angioplasty, Balloon | 6 | 2015 | 653 | 0.790 |
Why?
|
Fontan Procedure | 7 | 2019 | 778 | 0.780 |
Why?
|
Child | 88 | 2024 | 77709 | 0.760 |
Why?
|
Pediatrics | 10 | 2020 | 3475 | 0.750 |
Why?
|
Child Mortality | 3 | 2013 | 198 | 0.740 |
Why?
|
Tetralogy of Fallot | 4 | 2018 | 623 | 0.650 |
Why?
|
Infant Mortality | 3 | 2013 | 754 | 0.620 |
Why?
|
Norwood Procedures | 7 | 2019 | 182 | 0.620 |
Why?
|
Family Practice | 1 | 2020 | 516 | 0.610 |
Why?
|
Health Resources | 5 | 2017 | 911 | 0.600 |
Why?
|
Nutritional Support | 2 | 2018 | 168 | 0.600 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2017 | 197 | 0.590 |
Why?
|
Surgical Wound Infection | 3 | 2017 | 1540 | 0.570 |
Why?
|
Public Health Administration | 1 | 2019 | 240 | 0.570 |
Why?
|
Trisomy | 1 | 2017 | 266 | 0.560 |
Why?
|
Pulmonary Artery | 6 | 2019 | 1912 | 0.560 |
Why?
|
Heart Ventricles | 6 | 2019 | 3821 | 0.530 |
Why?
|
Heart Diseases | 5 | 2023 | 2788 | 0.530 |
Why?
|
Vascular Diseases | 4 | 2015 | 1161 | 0.530 |
Why?
|
Malnutrition | 2 | 2019 | 625 | 0.520 |
Why?
|
Evaluation Studies as Topic | 2 | 2016 | 1681 | 0.500 |
Why?
|
Hypoplastic Left Heart Syndrome | 9 | 2014 | 574 | 0.490 |
Why?
|
Prostheses and Implants | 5 | 2006 | 1387 | 0.480 |
Why?
|
Heart Septal Defects, Atrial | 5 | 2013 | 478 | 0.470 |
Why?
|
Cause of Death | 5 | 2018 | 3584 | 0.470 |
Why?
|
Registries | 16 | 2023 | 8089 | 0.470 |
Why?
|
Adolescent | 52 | 2024 | 85781 | 0.460 |
Why?
|
Population Surveillance | 4 | 2020 | 2616 | 0.450 |
Why?
|
Transposition of Great Vessels | 6 | 2017 | 588 | 0.450 |
Why?
|
Databases, Factual | 13 | 2019 | 7729 | 0.440 |
Why?
|
Hospitals, Pediatric | 8 | 2024 | 1775 | 0.430 |
Why?
|
Advisory Committees | 6 | 2013 | 775 | 0.430 |
Why?
|
Humans | 167 | 2024 | 744343 | 0.430 |
Why?
|
Fetal Diseases | 3 | 2014 | 903 | 0.430 |
Why?
|
Palliative Care | 12 | 2019 | 3493 | 0.420 |
Why?
|
Ambulatory Care | 5 | 2018 | 2708 | 0.420 |
Why?
|
Sirolimus | 1 | 2019 | 1564 | 0.420 |
Why?
|
Cardiology Service, Hospital | 4 | 2010 | 246 | 0.400 |
Why?
|
Consensus | 1 | 2020 | 2959 | 0.400 |
Why?
|
Diagnosis-Related Groups | 3 | 2010 | 455 | 0.390 |
Why?
|
Disease Management | 4 | 2018 | 2459 | 0.390 |
Why?
|
Surgical Procedures, Operative | 3 | 2012 | 1876 | 0.380 |
Why?
|
Heart Septal Defects, Ventricular | 4 | 2013 | 488 | 0.380 |
Why?
|
Male | 84 | 2021 | 350118 | 0.380 |
Why?
|
Weight Gain | 2 | 2018 | 2292 | 0.380 |
Why?
|
Child Health Services | 1 | 2016 | 667 | 0.380 |
Why?
|
Nutritional Status | 2 | 2018 | 1609 | 0.370 |
Why?
|
Female | 89 | 2022 | 380194 | 0.370 |
Why?
|
Stents | 6 | 2020 | 3280 | 0.360 |
Why?
|
Risk Assessment | 17 | 2019 | 23338 | 0.350 |
Why?
|
Personnel Staffing and Scheduling | 2 | 2011 | 501 | 0.350 |
Why?
|
Ventricular Function | 1 | 2011 | 416 | 0.350 |
Why?
|
Treatment Outcome | 42 | 2021 | 63114 | 0.340 |
Why?
|
Propanolamines | 2 | 2007 | 167 | 0.340 |
Why?
|
Nursing Staff | 1 | 2010 | 129 | 0.330 |
Why?
|
Thoracic Surgery | 4 | 2023 | 719 | 0.330 |
Why?
|
Pulmonary Valve Stenosis | 2 | 2008 | 183 | 0.320 |
Why?
|
Carbazoles | 2 | 2007 | 226 | 0.310 |
Why?
|
Retrospective Studies | 39 | 2024 | 77449 | 0.310 |
Why?
|
Angiogenesis Inhibitors | 1 | 2018 | 2038 | 0.310 |
Why?
|
Lymphatic System | 2 | 2010 | 253 | 0.310 |
Why?
|
Cross Infection | 1 | 2017 | 1416 | 0.310 |
Why?
|
Intraoperative Complications | 5 | 2011 | 1198 | 0.300 |
Why?
|
United States | 47 | 2020 | 69872 | 0.300 |
Why?
|
Radiography, Thoracic | 2 | 2013 | 1265 | 0.300 |
Why?
|
Child Development | 1 | 2018 | 2223 | 0.290 |
Why?
|
Sepsis | 2 | 2019 | 2593 | 0.280 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4149 | 0.280 |
Why?
|
Quality of Health Care | 9 | 2022 | 4371 | 0.280 |
Why?
|
Cardiovascular Abnormalities | 1 | 2007 | 144 | 0.280 |
Why?
|
Public Health | 2 | 2023 | 2603 | 0.280 |
Why?
|
Costs and Cost Analysis | 2 | 2022 | 1681 | 0.270 |
Why?
|
Odds Ratio | 11 | 2017 | 9849 | 0.270 |
Why?
|
Delphi Technique | 2 | 2020 | 778 | 0.270 |
Why?
|
Risk Factors | 34 | 2023 | 72290 | 0.270 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2008 | 272 | 0.270 |
Why?
|
Postoperative Complications | 14 | 2015 | 15295 | 0.260 |
Why?
|
Coronary Thrombosis | 1 | 2008 | 495 | 0.260 |
Why?
|
Mental Health Services | 1 | 2016 | 1643 | 0.250 |
Why?
|
Preoperative Care | 3 | 2011 | 2250 | 0.250 |
Why?
|
Adrenergic beta-Antagonists | 3 | 2012 | 1240 | 0.250 |
Why?
|
Arterial Occlusive Diseases | 2 | 2005 | 793 | 0.240 |
Why?
|
Quality Assurance, Health Care | 5 | 2013 | 2212 | 0.240 |
Why?
|
Bioprosthesis | 1 | 2008 | 596 | 0.230 |
Why?
|
Heart-Assist Devices | 2 | 2011 | 1194 | 0.230 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2007 | 851 | 0.220 |
Why?
|
Ticlopidine | 1 | 2008 | 899 | 0.220 |
Why?
|
International Cooperation | 3 | 2019 | 1420 | 0.210 |
Why?
|
Delivery of Health Care, Integrated | 4 | 2011 | 941 | 0.210 |
Why?
|
Exercise | 2 | 2010 | 5615 | 0.200 |
Why?
|
Cooperative Behavior | 8 | 2018 | 1504 | 0.200 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5535 | 0.200 |
Why?
|
Multivariate Analysis | 9 | 2017 | 12245 | 0.190 |
Why?
|
Societies, Medical | 6 | 2018 | 3743 | 0.190 |
Why?
|
Health Status | 4 | 2016 | 4034 | 0.190 |
Why?
|
Recovery of Function | 1 | 2011 | 2925 | 0.190 |
Why?
|
Hypertension, Pulmonary | 3 | 2017 | 1537 | 0.190 |
Why?
|
Logistic Models | 7 | 2017 | 13408 | 0.190 |
Why?
|
Exercise Therapy | 2 | 2010 | 906 | 0.190 |
Why?
|
Time Factors | 19 | 2018 | 40075 | 0.190 |
Why?
|
Clinical Competence | 4 | 2015 | 4687 | 0.190 |
Why?
|
Patient Admission | 2 | 2007 | 1380 | 0.190 |
Why?
|
Coronary Aneurysm | 1 | 2003 | 237 | 0.180 |
Why?
|
Benchmarking | 4 | 2018 | 1042 | 0.180 |
Why?
|
Prospective Studies | 14 | 2018 | 53288 | 0.180 |
Why?
|
Survival Analysis | 7 | 2019 | 10252 | 0.180 |
Why?
|
Age Factors | 7 | 2018 | 18370 | 0.170 |
Why?
|
Education, Medical, Continuing | 3 | 2014 | 840 | 0.170 |
Why?
|
Gross Domestic Product | 1 | 2019 | 77 | 0.170 |
Why?
|
Physical Fitness | 1 | 2023 | 733 | 0.170 |
Why?
|
Drug Prescriptions | 1 | 2008 | 1637 | 0.170 |
Why?
|
Death, Sudden, Cardiac | 2 | 2013 | 1541 | 0.160 |
Why?
|
Follow-Up Studies | 17 | 2018 | 39050 | 0.160 |
Why?
|
Relative Value Scales | 1 | 1998 | 84 | 0.160 |
Why?
|
Hemodynamics | 5 | 2011 | 4199 | 0.160 |
Why?
|
Cardiomegaly | 1 | 2001 | 620 | 0.160 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2003 | 546 | 0.150 |
Why?
|
Child Nutrition Disorders | 1 | 2019 | 149 | 0.150 |
Why?
|
Socioeconomic Factors | 4 | 2023 | 7785 | 0.150 |
Why?
|
Health Policy | 3 | 2017 | 2661 | 0.150 |
Why?
|
Smith-Lemli-Opitz Syndrome | 1 | 2017 | 46 | 0.150 |
Why?
|
Length of Stay | 10 | 2013 | 6309 | 0.150 |
Why?
|
Heart Transplantation | 7 | 2011 | 3110 | 0.150 |
Why?
|
Evidence-Based Medicine | 6 | 2011 | 3610 | 0.150 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2017 | 245 | 0.150 |
Why?
|
Boston | 8 | 2015 | 9313 | 0.150 |
Why?
|
Program Evaluation | 5 | 2017 | 2488 | 0.140 |
Why?
|
Patient Care Management | 2 | 2010 | 306 | 0.140 |
Why?
|
Probability | 5 | 2008 | 2505 | 0.140 |
Why?
|
Tunica Intima | 2 | 2017 | 464 | 0.140 |
Why?
|
Echocardiography | 9 | 2022 | 5102 | 0.140 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2010 | 3068 | 0.140 |
Why?
|
Quality of Life | 5 | 2022 | 12804 | 0.140 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2013 | 2073 | 0.140 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2017 | 101 | 0.140 |
Why?
|
Critical Pathways | 2 | 2010 | 476 | 0.140 |
Why?
|
Device Approval | 2 | 2009 | 163 | 0.140 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 2016 | 92 | 0.140 |
Why?
|
Survival Rate | 11 | 2018 | 12788 | 0.140 |
Why?
|
Drug and Narcotic Control | 1 | 2017 | 146 | 0.140 |
Why?
|
Pulmonary Atresia | 2 | 2008 | 160 | 0.140 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 2 | 2013 | 137 | 0.140 |
Why?
|
Vasodilator Agents | 2 | 2017 | 977 | 0.140 |
Why?
|
Medical Audit | 1 | 2017 | 467 | 0.130 |
Why?
|
Protein-Losing Enteropathies | 2 | 2008 | 45 | 0.130 |
Why?
|
Health Services Accessibility | 3 | 2019 | 5137 | 0.130 |
Why?
|
Stroke Volume | 3 | 2012 | 5007 | 0.130 |
Why?
|
Heart Failure | 5 | 2013 | 10900 | 0.130 |
Why?
|
Hospital Costs | 2 | 2013 | 985 | 0.130 |
Why?
|
Electrocardiography | 6 | 2010 | 6442 | 0.130 |
Why?
|
Denmark | 1 | 2017 | 738 | 0.130 |
Why?
|
Bottle Feeding | 1 | 2014 | 66 | 0.130 |
Why?
|
Psychometrics | 3 | 2020 | 3002 | 0.120 |
Why?
|
Chromosome Disorders | 1 | 2017 | 514 | 0.120 |
Why?
|
Social Class | 1 | 2023 | 1999 | 0.120 |
Why?
|
Aortic Valve Insufficiency | 2 | 2004 | 579 | 0.120 |
Why?
|
Hospital Charges | 3 | 2005 | 362 | 0.120 |
Why?
|
Equipment Failure | 3 | 2006 | 578 | 0.120 |
Why?
|
Adult | 32 | 2023 | 214055 | 0.120 |
Why?
|
American Heart Association | 3 | 2010 | 1056 | 0.120 |
Why?
|
Cardiac Output | 2 | 2010 | 854 | 0.120 |
Why?
|
Eisenmenger Complex | 1 | 2013 | 27 | 0.120 |
Why?
|
Morbidity | 4 | 2020 | 1769 | 0.120 |
Why?
|
Attitude to Health | 1 | 2003 | 2052 | 0.120 |
Why?
|
Young Adult | 12 | 2023 | 56430 | 0.110 |
Why?
|
Radiographic Image Enhancement | 2 | 2021 | 885 | 0.110 |
Why?
|
Body Height | 2 | 2018 | 1577 | 0.110 |
Why?
|
Hospitalization | 2 | 2016 | 10262 | 0.110 |
Why?
|
Infant Formula | 1 | 2014 | 199 | 0.110 |
Why?
|
Confidence Intervals | 3 | 2016 | 2971 | 0.110 |
Why?
|
Postoperative Care | 2 | 2017 | 1486 | 0.110 |
Why?
|
Internationality | 1 | 2018 | 1003 | 0.110 |
Why?
|
Off-Label Use | 2 | 2017 | 169 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2019 | 1530 | 0.110 |
Why?
|
Inservice Training | 1 | 2015 | 392 | 0.110 |
Why?
|
Research Report | 1 | 2015 | 355 | 0.110 |
Why?
|
Nursing Staff, Hospital | 2 | 2017 | 346 | 0.110 |
Why?
|
Exercise Test | 4 | 2010 | 2074 | 0.100 |
Why?
|
Referral and Consultation | 2 | 2015 | 3528 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1411 | 0.100 |
Why?
|
Patient Care Team | 4 | 2017 | 2531 | 0.100 |
Why?
|
Fetal Heart | 2 | 2006 | 276 | 0.100 |
Why?
|
Equipment Design | 6 | 2009 | 3582 | 0.100 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4933 | 0.100 |
Why?
|
Phlebography | 1 | 2013 | 333 | 0.100 |
Why?
|
Mass Screening | 1 | 2007 | 5255 | 0.100 |
Why?
|
Survivors | 3 | 2016 | 2291 | 0.100 |
Why?
|
Infant, Low Birth Weight | 1 | 2016 | 850 | 0.100 |
Why?
|
Primary Prevention | 1 | 2019 | 1167 | 0.100 |
Why?
|
Operating Room Nursing | 1 | 2011 | 26 | 0.100 |
Why?
|
Catheterization | 2 | 2011 | 1470 | 0.100 |
Why?
|
Workload | 2 | 2011 | 850 | 0.100 |
Why?
|
Twins, Conjoined | 2 | 2002 | 41 | 0.100 |
Why?
|
Age of Onset | 2 | 2012 | 3271 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6538 | 0.100 |
Why?
|
Primary Health Care | 3 | 2017 | 4558 | 0.100 |
Why?
|
Lung Diseases | 1 | 2021 | 1886 | 0.100 |
Why?
|
Pulmonary Valve | 2 | 1993 | 437 | 0.100 |
Why?
|
Wound Healing | 2 | 2001 | 2785 | 0.100 |
Why?
|
Nursing Service, Hospital | 1 | 2010 | 17 | 0.090 |
Why?
|
Oxygen Consumption | 3 | 2023 | 1869 | 0.090 |
Why?
|
Vinblastine | 1 | 2011 | 502 | 0.090 |
Why?
|
Pediatric Nursing | 1 | 2011 | 103 | 0.090 |
Why?
|
Lymphography | 1 | 2010 | 201 | 0.090 |
Why?
|
Life Tables | 3 | 2006 | 370 | 0.090 |
Why?
|
Peripheral Arterial Disease | 2 | 2010 | 1188 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6489 | 0.090 |
Why?
|
Abnormalities, Multiple | 1 | 2017 | 1416 | 0.090 |
Why?
|
Cohort Studies | 9 | 2015 | 40561 | 0.090 |
Why?
|
Health Care Costs | 2 | 2017 | 3209 | 0.090 |
Why?
|
Intensive Care Units | 1 | 2023 | 3679 | 0.090 |
Why?
|
Terminology as Topic | 2 | 2008 | 1547 | 0.090 |
Why?
|
Cardiotonic Agents | 2 | 2011 | 535 | 0.080 |
Why?
|
Medicaid | 1 | 2002 | 2736 | 0.080 |
Why?
|
Blood Flow Velocity | 2 | 2010 | 1423 | 0.080 |
Why?
|
Intracranial Aneurysm | 1 | 2018 | 1197 | 0.080 |
Why?
|
Vascular Surgical Procedures | 2 | 2015 | 1475 | 0.080 |
Why?
|
Safety | 2 | 2010 | 1186 | 0.080 |
Why?
|
Severity of Illness Index | 4 | 2013 | 15540 | 0.080 |
Why?
|
Organizational Objectives | 4 | 2011 | 438 | 0.080 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2009 | 194 | 0.080 |
Why?
|
Embolism | 2 | 2015 | 408 | 0.080 |
Why?
|
Medical Records | 1 | 2014 | 1413 | 0.080 |
Why?
|
Early Diagnosis | 1 | 2013 | 1184 | 0.080 |
Why?
|
Mortality | 2 | 2017 | 2864 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2016 | 19905 | 0.080 |
Why?
|
Heart Bypass, Right | 2 | 2008 | 74 | 0.080 |
Why?
|
Gestational Age | 2 | 2014 | 3493 | 0.080 |
Why?
|
Single-Blind Method | 1 | 2011 | 1590 | 0.080 |
Why?
|
Practice Guidelines as Topic | 7 | 2013 | 7279 | 0.080 |
Why?
|
United States Food and Drug Administration | 3 | 2017 | 1584 | 0.070 |
Why?
|
Checklist | 2 | 2011 | 833 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2593 | 0.070 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 1997 | 1534 | 0.070 |
Why?
|
Databases as Topic | 1 | 2008 | 475 | 0.070 |
Why?
|
Child Welfare | 2 | 2008 | 523 | 0.070 |
Why?
|
Attitude of Health Personnel | 3 | 2017 | 3843 | 0.070 |
Why?
|
Pilot Projects | 4 | 2020 | 8324 | 0.070 |
Why?
|
Massachusetts | 2 | 2016 | 8663 | 0.070 |
Why?
|
Tricuspid Valve | 3 | 2006 | 403 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2013 | 15076 | 0.070 |
Why?
|
Infant, Premature, Diseases | 1 | 2012 | 706 | 0.070 |
Why?
|
Prevalence | 3 | 2018 | 15226 | 0.070 |
Why?
|
Vena Cava, Superior | 2 | 2006 | 193 | 0.070 |
Why?
|
Breast Feeding | 1 | 2014 | 1338 | 0.070 |
Why?
|
Middle Aged | 13 | 2020 | 213383 | 0.070 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 1184 | 0.070 |
Why?
|
Prosthesis Implantation | 2 | 2001 | 642 | 0.070 |
Why?
|
Tachycardia, Ventricular | 2 | 2013 | 1273 | 0.070 |
Why?
|
Learning | 1 | 2015 | 1713 | 0.070 |
Why?
|
Case-Control Studies | 6 | 2015 | 21746 | 0.070 |
Why?
|
Gadolinium | 1 | 2010 | 952 | 0.070 |
Why?
|
Career Choice | 1 | 2012 | 744 | 0.070 |
Why?
|
Health Services Research | 4 | 2013 | 1836 | 0.070 |
Why?
|
Stress, Mechanical | 1 | 2010 | 1686 | 0.060 |
Why?
|
Reoperation | 4 | 2021 | 4201 | 0.060 |
Why?
|
Medical Errors | 1 | 2014 | 1297 | 0.060 |
Why?
|
Heart Atria | 3 | 1997 | 1357 | 0.060 |
Why?
|
Muscular Dystrophies | 1 | 2007 | 393 | 0.060 |
Why?
|
Clinical Trials as Topic | 3 | 2012 | 7913 | 0.060 |
Why?
|
Methotrexate | 1 | 2011 | 1727 | 0.060 |
Why?
|
Curriculum | 2 | 2015 | 3605 | 0.060 |
Why?
|
Body Surface Potential Mapping | 2 | 1997 | 238 | 0.060 |
Why?
|
Electrodes | 3 | 1997 | 619 | 0.060 |
Why?
|
Aged | 8 | 2019 | 163280 | 0.060 |
Why?
|
Statistics, Nonparametric | 2 | 2008 | 2886 | 0.060 |
Why?
|
Interdisciplinary Communication | 4 | 2011 | 950 | 0.060 |
Why?
|
Radiography | 4 | 2015 | 7023 | 0.060 |
Why?
|
Continuity of Patient Care | 3 | 2023 | 1049 | 0.060 |
Why?
|
California | 3 | 2011 | 1402 | 0.060 |
Why?
|
ROC Curve | 2 | 2010 | 3527 | 0.060 |
Why?
|
Fatal Outcome | 2 | 2017 | 1850 | 0.060 |
Why?
|
National Health Programs | 1 | 2007 | 445 | 0.060 |
Why?
|
Patient Education as Topic | 2 | 2012 | 2278 | 0.060 |
Why?
|
Echocardiography, Transesophageal | 3 | 2006 | 1133 | 0.060 |
Why?
|
Angiography | 2 | 2021 | 1639 | 0.060 |
Why?
|
Patient-Centered Care | 1 | 2014 | 1439 | 0.060 |
Why?
|
Comorbidity | 2 | 2012 | 10388 | 0.060 |
Why?
|
Internal Medicine | 1 | 2010 | 1009 | 0.060 |
Why?
|
India | 2 | 2023 | 2197 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2017 | 3923 | 0.060 |
Why?
|
Walking | 1 | 2010 | 1180 | 0.060 |
Why?
|
Thoracic Surgical Procedures | 2 | 2009 | 342 | 0.060 |
Why?
|
Infant, Premature | 1 | 2012 | 2044 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1738 | 0.050 |
Why?
|
Echocardiography, Doppler, Color | 2 | 2001 | 364 | 0.050 |
Why?
|
Fetofetal Transfusion | 2 | 2002 | 104 | 0.050 |
Why?
|
Exercise Tolerance | 1 | 2007 | 770 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2010 | 2453 | 0.050 |
Why?
|
Sensitivity and Specificity | 6 | 2015 | 14722 | 0.050 |
Why?
|
Cost Savings | 3 | 2013 | 926 | 0.050 |
Why?
|
Ultrasonography | 3 | 2020 | 5985 | 0.050 |
Why?
|
Catheter Ablation | 3 | 1997 | 2758 | 0.050 |
Why?
|
Heart Rate | 2 | 2010 | 4091 | 0.050 |
Why?
|
Europe | 1 | 2008 | 3339 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2014 | 3396 | 0.050 |
Why?
|
Sex Distribution | 1 | 2007 | 2297 | 0.050 |
Why?
|
Stroke | 3 | 2018 | 9981 | 0.050 |
Why?
|
Prosthesis Design | 2 | 2013 | 2110 | 0.050 |
Why?
|
Age Distribution | 1 | 2007 | 2902 | 0.050 |
Why?
|
Central Venous Pressure | 1 | 2000 | 78 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2008 | 1257 | 0.050 |
Why?
|
Radiography, Interventional | 1 | 2008 | 1095 | 0.050 |
Why?
|
Foreign-Body Reaction | 1 | 2001 | 157 | 0.050 |
Why?
|
Incidence | 5 | 2018 | 20947 | 0.050 |
Why?
|
Ultrasonography, Prenatal | 3 | 2022 | 1695 | 0.050 |
Why?
|
Blood Pressure | 3 | 2013 | 8554 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 9959 | 0.050 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2011 | 1354 | 0.050 |
Why?
|
Social Adjustment | 1 | 2003 | 631 | 0.050 |
Why?
|
Information Dissemination | 1 | 2008 | 1099 | 0.050 |
Why?
|
Maternal Exposure | 1 | 2007 | 961 | 0.050 |
Why?
|
Heart | 2 | 2010 | 4467 | 0.050 |
Why?
|
Embolism, Paradoxical | 1 | 2000 | 58 | 0.040 |
Why?
|
Coronary Angiography | 3 | 2006 | 4577 | 0.040 |
Why?
|
Cardiac Imaging Techniques | 1 | 2022 | 269 | 0.040 |
Why?
|
Transplantation, Homologous | 1 | 2008 | 4776 | 0.040 |
Why?
|
Aortic Valve | 2 | 2004 | 1922 | 0.040 |
Why?
|
Imaging, Three-Dimensional | 1 | 2013 | 4042 | 0.040 |
Why?
|
Program Development | 3 | 2010 | 1316 | 0.040 |
Why?
|
Cost-Benefit Analysis | 3 | 2021 | 5391 | 0.040 |
Why?
|
Internet | 1 | 2011 | 3064 | 0.040 |
Why?
|
Endocardium | 2 | 1997 | 263 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2008 | 1239 | 0.040 |
Why?
|
Coronary Artery Disease | 1 | 2018 | 6487 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9687 | 0.040 |
Why?
|
Sheep | 3 | 2000 | 1437 | 0.040 |
Why?
|
Fee Schedules | 1 | 1998 | 86 | 0.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2006 | 1660 | 0.040 |
Why?
|
Prognosis | 4 | 2011 | 29063 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2010 | 3589 | 0.040 |
Why?
|
Research Design | 1 | 2013 | 5987 | 0.040 |
Why?
|
Tachycardia, Supraventricular | 2 | 1997 | 263 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2003 | 859 | 0.040 |
Why?
|
Medicare Part B | 1 | 1998 | 108 | 0.040 |
Why?
|
Child Advocacy | 1 | 2017 | 50 | 0.040 |
Why?
|
Algorithms | 3 | 2013 | 13881 | 0.040 |
Why?
|
Ambulatory Care Facilities | 1 | 2003 | 933 | 0.040 |
Why?
|
Developmental Disabilities | 1 | 2005 | 1456 | 0.040 |
Why?
|
Income | 1 | 2006 | 1913 | 0.040 |
Why?
|
Drug Approval | 2 | 2017 | 742 | 0.040 |
Why?
|
Pregnancy | 5 | 2022 | 29144 | 0.040 |
Why?
|
Quebec | 1 | 2016 | 134 | 0.040 |
Why?
|
Pakistan | 1 | 2017 | 295 | 0.030 |
Why?
|
Lung | 2 | 2015 | 9856 | 0.030 |
Why?
|
Cognition | 1 | 2014 | 6770 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3507 | 0.030 |
Why?
|
Patient Transfer | 1 | 2003 | 761 | 0.030 |
Why?
|
Device Removal | 1 | 2001 | 656 | 0.030 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 2015 | 67 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2001 | 1206 | 0.030 |
Why?
|
Therapeutics | 1 | 2016 | 116 | 0.030 |
Why?
|
Educational Status | 1 | 2024 | 2540 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2003 | 1320 | 0.030 |
Why?
|
Cross-Sectional Studies | 4 | 2018 | 25043 | 0.030 |
Why?
|
Random Allocation | 1 | 2000 | 2429 | 0.030 |
Why?
|
Graft Rejection | 1 | 2008 | 4397 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2022 | 20129 | 0.030 |
Why?
|
Nurse's Role | 1 | 2017 | 209 | 0.030 |
Why?
|
Hospitals, University | 1 | 2017 | 571 | 0.030 |
Why?
|
Amiloride | 1 | 1985 | 121 | 0.030 |
Why?
|
Dietary Supplements | 1 | 2007 | 3297 | 0.030 |
Why?
|
Ischemic Attack, Transient | 1 | 2000 | 935 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 7 | 2013 | 35421 | 0.030 |
Why?
|
Defibrillators, Implantable | 2 | 2013 | 1440 | 0.030 |
Why?
|
Policy Making | 1 | 2017 | 554 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2000 | 1236 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 2 | 2000 | 2268 | 0.030 |
Why?
|
Government Regulation | 1 | 2017 | 522 | 0.030 |
Why?
|
Body Weight | 3 | 2011 | 4669 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2005 | 6993 | 0.030 |
Why?
|
Reimbursement Mechanisms | 1 | 1998 | 670 | 0.030 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2013 | 981 | 0.030 |
Why?
|
Thrombosis | 1 | 2006 | 2968 | 0.030 |
Why?
|
Ultrasonography, Interventional | 1 | 2020 | 1486 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2003 | 2576 | 0.030 |
Why?
|
Aortic Valve Stenosis | 1 | 2004 | 1965 | 0.030 |
Why?
|
Swine | 2 | 2010 | 5917 | 0.030 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2013 | 151 | 0.030 |
Why?
|
Platinum | 1 | 2013 | 233 | 0.030 |
Why?
|
Critical Care | 2 | 2017 | 2647 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2014 | 723 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2001 | 1956 | 0.020 |
Why?
|
Accreditation | 1 | 2014 | 450 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2015 | 2031 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2016 | 1254 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 2013 | 426 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2010 | 1572 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10943 | 0.020 |
Why?
|
Texas | 1 | 2011 | 392 | 0.020 |
Why?
|
Dendrimers | 1 | 2010 | 68 | 0.020 |
Why?
|
Ankle Brachial Index | 1 | 2010 | 154 | 0.020 |
Why?
|
Myofibroblasts | 1 | 2011 | 222 | 0.020 |
Why?
|
Ion Channels | 1 | 1985 | 1056 | 0.020 |
Why?
|
Infection Control | 1 | 2017 | 966 | 0.020 |
Why?
|
Echocardiography, Stress | 1 | 2010 | 131 | 0.020 |
Why?
|
Catheterization, Peripheral | 1 | 2013 | 345 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2013 | 1525 | 0.020 |
Why?
|
Sodium | 1 | 1985 | 1623 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2022 | 2214 | 0.020 |
Why?
|
Radioisotopes | 1 | 2010 | 499 | 0.020 |
Why?
|
Oxygen | 1 | 2000 | 4189 | 0.020 |
Why?
|
Adrenergic Agonists | 1 | 2008 | 58 | 0.020 |
Why?
|
Patient Selection | 2 | 2011 | 4215 | 0.020 |
Why?
|
Hindlimb | 1 | 2010 | 504 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2010 | 440 | 0.020 |
Why?
|
Therapies, Investigational | 1 | 2009 | 112 | 0.020 |
Why?
|
Linear Models | 1 | 1998 | 5952 | 0.020 |
Why?
|
Furosemide | 1 | 2008 | 167 | 0.020 |
Why?
|
Classification | 1 | 2008 | 129 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2013 | 681 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2007 | 6365 | 0.020 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2007 | 72 | 0.020 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2008 | 135 | 0.020 |
Why?
|
Oximetry | 1 | 2011 | 471 | 0.020 |
Why?
|
Guatemala | 1 | 2007 | 142 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2008 | 588 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2011 | 767 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2013 | 5078 | 0.020 |
Why?
|
Brazil | 1 | 2011 | 1270 | 0.020 |
Why?
|
Health Care Rationing | 1 | 2010 | 437 | 0.020 |
Why?
|
Computer Simulation | 1 | 2000 | 6196 | 0.020 |
Why?
|
Waiting Lists | 2 | 2001 | 692 | 0.020 |
Why?
|
Recurrence | 2 | 2013 | 8340 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2017 | 2569 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15165 | 0.020 |
Why?
|
Office Visits | 1 | 2010 | 598 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2008 | 981 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2645 | 0.020 |
Why?
|
Heart Septum | 1 | 2006 | 313 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 1518 | 0.020 |
Why?
|
Forecasting | 2 | 2006 | 2951 | 0.020 |
Why?
|
Epinephrine | 1 | 2008 | 792 | 0.020 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2009 | 430 | 0.020 |
Why?
|
Heart Arrest | 2 | 2010 | 1470 | 0.020 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2011 | 780 | 0.020 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2010 | 554 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2007 | 585 | 0.020 |
Why?
|
Aortic Diseases | 1 | 2010 | 742 | 0.020 |
Why?
|
Home Care Services | 1 | 2011 | 606 | 0.020 |
Why?
|
Outpatients | 1 | 2012 | 1486 | 0.020 |
Why?
|
Sex Factors | 1 | 2018 | 10397 | 0.010 |
Why?
|
Task Performance and Analysis | 1 | 2008 | 780 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2009 | 969 | 0.010 |
Why?
|
Models, Animal | 1 | 2010 | 2171 | 0.010 |
Why?
|
Delivery of Health Care | 2 | 2013 | 5319 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2000 | 12354 | 0.010 |
Why?
|
Sample Size | 1 | 2007 | 845 | 0.010 |
Why?
|
Infant Welfare | 1 | 2003 | 81 | 0.010 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2006 | 277 | 0.010 |
Why?
|
Regression Analysis | 1 | 2013 | 6459 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2000 | 8949 | 0.010 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1536 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2006 | 987 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2018 | 57776 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2010 | 1873 | 0.010 |
Why?
|
Germany | 1 | 2004 | 862 | 0.010 |
Why?
|
Parents | 1 | 2016 | 3407 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 2007 | 1585 | 0.010 |
Why?
|
Ventricular Function, Right | 2 | 1997 | 591 | 0.010 |
Why?
|
Dopamine | 1 | 2008 | 1591 | 0.010 |
Why?
|
Skin | 1 | 1985 | 4364 | 0.010 |
Why?
|
Echocardiography, Doppler | 1 | 2004 | 935 | 0.010 |
Why?
|
Inpatients | 1 | 2012 | 2518 | 0.010 |
Why?
|
Reference Values | 1 | 2007 | 4982 | 0.010 |
Why?
|
Population Dynamics | 1 | 2002 | 302 | 0.010 |
Why?
|
Rabbits | 1 | 2006 | 4894 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2000 | 18029 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2003 | 924 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2010 | 3474 | 0.010 |
Why?
|
Animals | 6 | 2010 | 168757 | 0.010 |
Why?
|
Patient Readmission | 1 | 2013 | 3114 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2716 | 0.010 |
Why?
|
Patient Discharge | 1 | 2011 | 3313 | 0.010 |
Why?
|
Congresses as Topic | 1 | 2002 | 764 | 0.010 |
Why?
|
Atrial Function, Right | 1 | 1997 | 33 | 0.010 |
Why?
|
Contrast Media | 1 | 2010 | 5300 | 0.010 |
Why?
|
Ecchymosis | 1 | 1997 | 32 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2003 | 1301 | 0.010 |
Why?
|
HIV Infections | 1 | 2003 | 16718 | 0.010 |
Why?
|
Embolism, Air | 1 | 1997 | 111 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10481 | 0.010 |
Why?
|
Rana catesbeiana | 1 | 1985 | 86 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 1985 | 223 | 0.010 |
Why?
|
Photolysis | 1 | 1985 | 92 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1985 | 220 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2007 | 3670 | 0.010 |
Why?
|
Atrial Flutter | 1 | 1997 | 263 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2003 | 2418 | 0.010 |
Why?
|
Electrophysiology | 1 | 1997 | 1308 | 0.010 |
Why?
|
Hypertension | 1 | 2013 | 8480 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11366 | 0.010 |
Why?
|
Blood Volume | 1 | 1993 | 565 | 0.010 |
Why?
|
Methylation | 1 | 1985 | 1106 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2002 | 2759 | 0.010 |
Why?
|
Cicatrix | 1 | 1997 | 764 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2002 | 1901 | 0.010 |
Why?
|
Caregivers | 1 | 2002 | 2094 | 0.010 |
Why?
|
Health Behavior | 1 | 2002 | 2636 | 0.010 |
Why?
|
Epithelium | 1 | 1985 | 1679 | 0.010 |
Why?
|
Insurance, Health | 1 | 2002 | 2494 | 0.010 |
Why?
|
Disease Progression | 1 | 2006 | 13284 | 0.010 |
Why?
|
Coronary Circulation | 1 | 1993 | 1572 | 0.000 |
Why?
|
Mass Spectrometry | 1 | 1985 | 2203 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 2003 | 13989 | 0.000 |
Why?
|
Kinetics | 1 | 1985 | 6473 | 0.000 |
Why?
|
Cell Membrane | 1 | 1985 | 3748 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1985 | 3760 | 0.000 |
Why?
|
Mice | 1 | 2010 | 81183 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1985 | 19229 | 0.000 |
Why?
|